Sonoma Pharmaceuticals, Inc.
corporate_fare Company Profile
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for SNOA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for SNOA spans S-3, 10-Q, DEFA14A, 424B5.
Recent high-impact activity:
- Sonoma Files New $46.65M Shelf to Replace Expiring S-3
- Sonoma Posts $2.8M Q2 Gross Profit as Revenue Jumps 28% to $7.2M
- Sonoma Q2 Revenue Up 28% to $7.2M, Near Breakeven; WellSpring Contract Terminated
- Sonoma Pharma Q1 Revenue Jumps 60% to $6.4M, Nears Breakeven
- Sonoma Nears Breakeven as Revenue Jumps 60%, But Nasdaq Delisting Risk Looms
Financial Snapshot
Short Interest & Short Volume
1.67 days to coverFINRA reported short interest of 66,674 shares in SNOA as of the October 30, 2026 settlement, a 38.7% decrease from the prior period — about 1.7 days to cover at its recent average daily volume. On November 20, 2026, 21.8% of SNOA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for SNOA, detected from its recent SEC filings · based on capital-structure filings through 2026-06-18.
ATM Program Expansion · Recent Stock Sales Reported
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →